Individual mammalian cells contain billions of protein molecules, which must be synthesized, deployed, and removed with ...

In the world of protein degradation, sometimes a spanner in the works isn’t an inconvenience but the desired result. Paris-based Enodia Therapeutics has launched out of France’s Pasteur Institute and ...

Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.

A collaboration led by CeMM, AITHYRA both in Vienna, Austria and the Max Planck Institute of Molecular Physiology in Dortmund ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

Relapses in a common form of leukemia may be preventable following new research which has identified how the cancer develops resistance to first line treatments. New research published in iScience by ...

Scientists at Johns Hopkins Medicine say results of a new National Institutes of Health-funded study are advancing efforts to exploit a new target for Alzheimer's disease: a protein that manufactures ...

A protein that produces hydrogen sulfide may be a new therapeutic target, as its deficiency is linked to cognitive deficits ...

Johns Hopkins researchers identified a new target for treating Alzheimer’s disease by focusing on a protein that produces tiny amounts of hydrogen sulfide in healthy brain cells. Mice genetically ...

CSE protein plays a crucial role in cognition, making it a potential therapeutic target for Alzheimer’s disease.